Last Posted: Sep 03, 2020
- Advances in Genetic Characterization and Genotype–Phenotype Correlation of Duchenne and Becker Muscular Dystrophy in the Personalized Medicine Era
O Sheikh et al, JPM, September 3, 2020 - Diagnosing Muscular Dystrophies: Comparison of Techniques and Their Cost Effectiveness: A Multi-institutional Study.
Srivastava Pallavi et al. Journal of neurosciences in rural practice 2020 Jul 11(3) 420-429 - Case Studies on the Genetic and Clinical Diagnosis of Facioscapulohumeral Muscular Dystrophy.
Hamel Johanna et al. Neurologic clinics 2020 38(3) 529-540 - A Boy With Muscular Dystrophy Was Headed For A Wheelchair. Then Gene Therapy Arrived
J Hamilton, NPR, July 27, 2020 - Evaluating the Diagnostic and Prognostic Value of Biomarkers for Heart Disease and Major Adverse Cardiac Events in Patients With Muscular Dystrophy.
Nikhanj Anish et al. European heart journal. Quality of care & clinical outcomes 2020 Jul - Open communication of Duchenne muscular dystrophy facilitates disclosure process by parents to unaffected siblings.
Sulmonte Laura A G et al. Journal of genetic counseling 2020 Jul - [Clinical Ethics in Hereditary Neuromuscular Diseases such as Duchenne Muscular Dystrophy].
Nakajima Takashi et al. Brain and nerve = Shinkei kenkyu no shinpo 2020 Jul 72(7) 753-766 - Impact of next-generation sequencing panels in the evaluation of limb-girdle muscular dystrophies.
Özyilmaz Berk et al. Annals of human genetics 2019 83(5) 331-347 - Comprehensive genetic analysis of 961 unrelated Duchenne Muscular Dystrophy patients: Focus on diagnosis, prevention and therapeutic possibilities.
Kumar Shalini H et al. PloS one 2020 15(6) e0232654 - Assessment of Systemic Delivery of rAAVrh74.MHCK7.micro-dystrophin in Children With Duchenne Muscular Dystrophy- A Nonrandomized Controlled Trial
JR Mendell et al, JAMA Neurology, June 15, 2020
.png)
No hay comentarios:
Publicar un comentario